Ask most people what changes during the menstrual cycle and they will point to the ovaries and the uterine lining. The blood coursing through the rest of the body rarely gets a mention. A new study says it should. When researchers looked at thousands of proteins floating in women's plasma, they found the cycle written all over them.
The work, published in Nature Medicine, drew on the UK Biobank. Researchers measured nearly 3,000 circulating proteins in plasma samples from 2,760 women. Then they asked a simple question: does the level of any given protein depend on where a woman is in her cycle? For 198 proteins, the answer was yes. Their concentrations rose and fell in patterns that lined up with menstrual phases, tracing out distinct temporal waves rather than random noise.
What the proteins were doing there
The 198 hits were not a grab bag of unrelated molecules. Many were reproductive hormones, cytokines, and growth factors. When the team checked where these proteins are normally made, a lot of them turned out to be enriched in endometrial tissue and expressed in the epithelial and stromal cells that build and shed the uterine lining each month. That biological specificity matters. It suggests the blood is not just picking up vague hormonal weather but reflecting the actual tissue that remodels itself on a monthly schedule.
Some of the proteins carried a heavier clinical meaning. Several were linked to common reproductive disorders, including endometriosis, uterine fibroids (leiomyoma), and abnormal uterine bleeding. Conditions like endometriosis are notoriously slow to diagnose, often taking years from first symptom to a name. A protein that shifts with both the cycle and the disease is exactly the kind of signal that biomarker research chases.
Turning the signal into a readout
The headline result for a diagnostics audience is the score. From the full set of cycle-linked proteins, the team built a proteomic model based on 75 of them. Feed it a plasma sample and it predicts which phase of the menstrual cycle the sample came from, and it does so accurately. That is a real tool, not just an observation. It turns a messy biological rhythm into something a lab can read from a single blood draw.
Why would anyone want that? Cycle phase is a hidden variable in a huge amount of clinical research and care. Drug levels, immune responses, and countless lab values can drift depending on the day of the cycle, yet studies often ignore it or rely on women's self-reported dates, which are imperfect. An objective molecular clock could let researchers control for that variation instead of guessing. For fertility work, it offers another way to pin down timing. And because the same proteins touch disorders like endometriosis, the score hints at a path toward blood tests that flag disease alongside phase.
Where the caveats sit
A few things are worth keeping in view. This is an atlas and a proof of concept, built from one large cohort. The score predicts cycle phase well within that population, but a model that shines on UK Biobank data still has to prove itself on women of different ages, ancestries, and health backgrounds before anyone leans on it clinically. The 198 proteins also describe associations. Showing that a protein tied to endometriosis moves with the cycle is a strong lead, but it does not by itself establish that measuring it would catch the disease earlier or better than existing approaches. Those are the next studies, not this one.
What the paper delivers is a systems-level map of something that has been oddly under-measured given how fundamental it is. The menstrual cycle is one of the most basic rhythms in human biology, and until now its fingerprint on the wider circulating proteome was mostly a blank. Filling in that blank with 198 named proteins, and a working score built from 75 of them, gives women's health research a concrete new place to start. According to PubMed, the study appeared in Nature Medicine (doi.org/10.1038/s41591-026-04326-5).
Comments